Larson SM - Search Results

1

A novel method to localize antibody-targeted cancer deposits intraoperatively using handheld PET beta and gamma probes.

Strong VE, Humm J, Russo P, Jungbluth A, Wong WD, Daghighian F, Old L, Fong Y, Larson SM. Strong VE, et al. Among authors: larson sm. Surg Endosc. 2008 Feb;22(2):386-91. doi: 10.1007/s00464-007-9611-3. Epub 2007 Nov 20. Surg Endosc. 2008. PMID: 18027053

2

The correct dose: pharmacologically guided end point for anti-growth factor therapy.

Mulshine JL, Shuke N, Daghighian F, Carrasquillo J, Ghosh B, Walsh T, Avis I, Reynolds JC, Cuttitta F, Larson SM. Mulshine JL, et al. Among authors: larson sm. Cancer Res. 1992 May 1;52(9 Suppl):2743s-2746s. Cancer Res. 1992. PMID: 1314137

3

PET scanning of iodine-124-3F9 as an approach to tumor dosimetry during treatment planning for radioimmunotherapy in a child with neuroblastoma.

Larson SM, Pentlow KS, Volkow ND, Wolf AP, Finn RD, Lambrecht RM, Graham MC, Di Resta G, Bendriem B, Daghighian F, et al. Larson SM, et al. J Nucl Med. 1992 Nov;33(11):2020-3. J Nucl Med. 1992. PMID: 1432165 Free article.

4

Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy.

Pentlow KS, Graham MC, Lambrecht RM, Cheung NK, Larson SM. Pentlow KS, et al. Among authors: larson sm. Med Phys. 1991 May-Jun;18(3):357-66. doi: 10.1118/1.596728. Med Phys. 1991. PMID: 1870476

5

Radioimmunology. Imaging and therapy.

Larson SM. Larson SM. Cancer. 1991 Feb 15;67(4 Suppl):1253-60. doi: 10.1002/1097-0142(19910215)67:4+<1253::aid-cncr2820671523>3.0.co;2-j. Cancer. 1991. PMID: 1991286 Review.

6

Clinical radioimmunodetection, 1978-1988: overview and suggestions for standardization of clinical trials.

Larson SM. Larson SM. Cancer Res. 1990 Feb 1;50(3 Suppl):892s-898s. Cancer Res. 1990. PMID: 2404583 Review.

7

Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors.

Arbit E, Cheung NK, Yeh SD, Daghighian F, Zhang JJ, Cordon-Cardo C, Pentlow K, Canete A, Finn R, Larson SM. Arbit E, et al. Among authors: larson sm. Eur J Nucl Med. 1995 May;22(5):419-26. doi: 10.1007/BF00839056. Eur J Nucl Med. 1995. PMID: 7641750

8

Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49.

Kostakoglu L, Divgi CR, Hilton S, Cordon-Cardo C, Scott AM, Kalaigian H, Finn RD, Schlom J, Larson SM. Kostakoglu L, et al. Among authors: larson sm. Cancer Invest. 1994;12(6):551-8. doi: 10.3109/07357909409023039. Cancer Invest. 1994. PMID: 7994589 Clinical Trial.

9

Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.

Welt S, Divgi CR, Scott AM, Garin-Chesa P, Finn RD, Graham M, Carswell EA, Cohen A, Larson SM, Old LJ, et al. Welt S, et al. Among authors: larson sm. J Clin Oncol. 1994 Jun;12(6):1193-203. doi: 10.1200/JCO.1994.12.6.1193. J Clin Oncol. 1994. PMID: 8201382 Clinical Trial.

10

Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancer.

Rubin SC, Kostakoglu L, Divgi C, Federici MG, Finstad CL, Lloyd KO, Larson SM, Hoskins WJ. Rubin SC, et al. Among authors: larson sm. Gynecol Oncol. 1993 Oct;51(1):61-6. doi: 10.1006/gyno.1993.1247. Gynecol Oncol. 1993. PMID: 8244176 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters